Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers

NCT01406925 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Fecal Incontinence

Interventions

DRUG: Placebo control
DRUG: NRL001 cream

Sponsor

Norgine